Based on elucidated biology of ASXL1 mutations, results from SELLAS’ clinical trials in acute myeloid leukemia (AML), and reports of common occurrence of ASXL1 mutations in some solid cancers, the ...
Based on elucidated biology of ASXL1 mutations, results from SELLAS ... of revumenib (drug used in hematologic malignancies). Positive controls involved cell lines treated with staurosporine ...
Based on elucidated biology of ASXL1 mutations, results from SELLAS’ clinical trials in acute myeloid leukemia ... while active negative control varying concentrations of revumenib (drug used in ...